GENE ONLINE|News &
Opinion
Blog

R&D
Asia-Pacific Atopic Dermatitis
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
R&D Classical Hodgkin Lymphoma
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
R&D
Biogen-Sangamo Collaboration Comforts Millions Affected by Neurodegenerative Disorders
2020-02-29
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
R&D Antibody-Drug Conjugate
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
R&D
SCLC Treatment Gets a Boost as PharmaMar’s Lurbinectedin Bags Priority Review Status
2020-02-19
Trials & Approvals
VEGF Inhibitor, Beovu Gets EC Approval for Wet Age-Related Macular Degeneration Treatment
2020-02-18
Trials & Approvals Multiple Myeloma
GSK Wins EMA Approval to Market Multiple Myeloma Treatment
2020-02-16
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Trials & Approvals Multiple Sclerosis
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
Blood Sample
Eisai Partners with PGDx To Develop Liquid Biopsy NGS Tool Against Cancer
2020-02-06
Trials & Approvals H5N1
Seqirus’ AUDENZTM, a Vaccine against Potential Flu Epidemic Gets FDA Approval
2020-02-05
COVID-19 Vaccine
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
R&D
Insmed Soaring High with Positive Phase II Results for Non Cystic Fibrosis Bronchiectasis Drug, INS1007
2020-02-03
Trials & Approvals Gene Therapy
FDA Issues Guidances Supporting Development of Gene Therapy Products
2020-02-02
1 … 29 30 31 32 33 34
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top